FDA STATE_REFERRAL_LETTER - Morton Drug Company dba Morton LTC - August 29, 2018

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This STATE REFERRAL LETTER record concerns Morton Drug Company dba Morton LTC, with an inspection on August 29, 2018, issued by the Office of Regulatory Affairs, covering biologics.

Company: Morton Drug Company dba Morton LTC
Inspection Date: August 29, 2018
Product Type: Biologics
Office: Office of Regulatory Affairs
People: Debra Sybell
Art O. Czabaniuk (Program Division Director)
Jeffrey D. Meng (Associate Director)
Stephen C. Motton
Brian W. Garthwaite

Open in Dashboard

ID · 52d7734d-7710-42f8-bea7-6657061292db

Violation Codes3

21 CFR 20.64(d)(3)21 CFR 20.88FD&C Act 503A(a)

Full citation text and observation details available on the Dashboard.